SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
46.98
-0.01 (-0.02%)
At close: Jun 27, 2025, 4:00 PM
46.99
+0.01 (0.02%)
After-hours: Jun 27, 2025, 7:46 PM EDT
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for SpringWorks Therapeutics stock ranges from a low of $47 to a high of $77. The average analyst price target of $56.86 forecasts a 21.03% increase in the stock price over the next year.
Price Target: $56.86 (+21.03%)
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for SpringWorks Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Reiterates $47 | Hold | Reiterates | $47 | +0.04% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $74 → $47 | Strong Buy → Hold | Downgrades | $74 → $47 | +0.04% | Apr 30, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades $77 → $47 | Strong Buy → Hold | Downgrades | $77 → $47 | +0.04% | Apr 29, 2025 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $66 → $47 | Strong Buy → Hold | Downgrades | $66 → $47 | +0.04% | Apr 29, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $63 → $47 | Buy → Hold | Downgrades | $63 → $47 | +0.04% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
334.05M
from 191.59M
Increased by 74.36%
Revenue Next Year
586.68M
from 334.05M
Increased by 75.63%
EPS This Year
-2.81
from -3.48
EPS Next Year
-1.51
from -2.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 417.5M | 753.1M | 1.2B | ||
| Avg | 334.1M | 586.7M | 805.9M | ||
| Low | 269.4M | 435.0M | 630.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 117.9% | 125.4% | 102.5% | ||
| Avg | 74.4% | 75.6% | 37.4% | ||
| Low | 40.6% | 30.2% | 7.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.59 | -0.23 | 3.05 | ||
| Avg | -2.81 | -1.51 | 1.21 | ||
| Low | -4.08 | -2.69 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.